# Acurx Pharmaceuticals, Inc.: Form DEF 14A, filed Aug 4, 2025

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: DEF 14A
- Filed: 2025-08-04
- Accepted by EDGAR: Aug 5, 2025, 09:19 ET
- Period: 2025-09-16
- Accession: 0001104659-25-073623
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925073623/tm2521566-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465925073623/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465925073623/tm2521566-2_def14a.htm

Filed Aug 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-073623. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.